Evaluation of Cellular Immune Responses After mRNA-1273 Vaccination in Children 6 Months to 11 Years of Agejeanfrancoismaison1 day ago1 min readRated NaN out of 5 stars.https://pubmed.ncbi.nlm.nih.gov/40119775/
Discovery of novel and selective GPR17 antagonists as pharmacological tools for developing new therapeutic strategies in diabetes and obesityhttps://pubmed.ncbi.nlm.nih.gov/40460721/
Risk of COVID-19 reinfection and vaccine breakthrough infection, Madera County, California, 2021https://pubmed.ncbi.nlm.nih.gov/39191647/
Intrinsic immunogenicity is a major determinant of type-specific responses in SARS-CoV-2 infectionshttps://pubmed.ncbi.nlm.nih.gov/40425779/
Comments